# Alpine Immune Sciences, Inc. Common Stock (ALPN)

Alpine Immune Sciences (ALPN) stock hits a 1-year high driven by positive Povetacicept trial data and insider activity, despite a near 52-week low in market dominance. Recent social posts highlight potential BD opportunities and licensing deals.

### About Alpine Immune Sciences, Inc. Common Stock
Alpine Immune Sciences, Inc. is a healthcare company focused on immunology.  
Alpine Immune Sciences, Inc. Common Stock uses the ticker $ALPN for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Alpine Immune Sciences, Inc. Common Stock (ALPN) market dominance near a 52-week low at [-------].
- Alpine Immune Sciences, Inc. Common Stock (ALPN) creators is up 25% from the previous week.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) engagements is up 1905.7% from the previous week.

### Price: $65
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/close.tsv)  
The stock price has reached a 1-year high, driven by positive clinical trial data for Povetacicept and insider transactions, which are currently outweighing a near 52-week low in market dominance.  

1-Year High: $65 on 2025-02-16  
1-Year Low: $65 on 2025-02-16  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/alt_rank.tsv)  
Alpine Immune Sciences, Inc. Common Stock (ALPN) is currently AltRank #1,666 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +81  
[--] Month: [-----] [----]  
[--] Months: [-----] +9  
[--] Year: [-----] [----]  
1-Year High: [-----] on 2026-02-03  
1-Year Low: [---] on 2025-03-22  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-03-03  
1-Year Low: [--] on 2025-06-05  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [-----] +1,906%  
[--] Month: [------] +53%  
[--] Months: [------] -42%  
[--] Year: [-------] -97%  
1-Year High: [-----] on 2026-01-21  
1-Year Low: [--] on 2026-01-29  

Engagements by network (24h):
Reddit: [--]
X: [---]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] no change  
[--] Month: [--] -15%  
[--] Months: [---] -62%  
[--] Year: [---] -68%  
1-Year High: [--] on 2025-02-19  
1-Year Low: [--] on 2025-12-19  

Mentions by network (24h):
Reddit: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Alpine Immune Sciences, Inc. Common Stock (ALPN) in the last [--] hours which is up 20% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +25%  
[--] Month: [--] -21%  
[--] Months: [--] -46%  
[--] Year: [---] -74%  
1-Year High: [--] on 2025-03-23  
1-Year Low: [--] on 2025-09-06  

The most influential creators that mention Alpine Immune Sciences, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | [--]    | [-----]     | [--]     | [--]           |

[View More](/list/creators/$alpn/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 59%  
[--] Month: 100% no change  
[--] Months: 100% +60%  
[--] Year: 100% +33%  
1-Year High: 100% on 2025-06-19  
1-Year Low: 25% on 2025-03-11  

Most Supportive Themes:
- Positive Clinical Trial Data: (50%) Positive clinical trial data for Povetacicept is driving stock price increases.
- Insider Transactions: (30%) Insider transactions are contributing to the stock's upward momentum.
  
Most Critical Themes:
- Near 52-Week Low in Market Dominance: (20%) The stock is experiencing a near 52-week low in market dominance, which could indicate potential downside risk.
  
  
  
### Social Dominance: 0.0005354573140122486%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/social_dominance.tsv)  
Current Value: 0.0005354573140122486%  
Daily Average: 0.00176%  
[--] Week: 0.00047% -0.00023%  
[--] Month: 0.001% +0.0006000000000000001%  
[--] Months: 0.001% -0.0005%  
[--] Year: 0.001% -0.0005%  
1-Year High: 0.016% on 2025-02-19  
1-Year Low: 0.0001% on 2025-12-19  
  
  
### Market Dominance: 0.00505%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/market_dominance.tsv)  
Current Value: 0.00505%  
Daily Average: 0%  
1-Year High: 0.00678% on 2025-04-08  
1-Year Low: 0.00499% on 2026-01-27  

### Top Alpine Immune Sciences, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Feel like $VRTX will do biotech investors & $XBI on the whole a solid in coming years in terms of BD $ALPN for $4.9B in cash was back in April [----] Since then it's been crickets mainly license deals such as recent preclinical trispecific T cell engager from WuXi Biologics"  
[X Link](https://x.com/jfais20/status/2022298605520932943) [@jfais20](/creator/x/jfais20) 2026-02-13T13:15Z 11.5K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing